Top story Rare‑Disease Biotechs Push Back on Trump’s Price‑Cut Push While PBMs Slip Around State Laws
The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability
Florida's Arthritis Patients Face a Looming Threat: Is Washington's Drug Pricing Plan Stifling the Hope for New Cures?
When Healthcare Hits a Wall: Thousands of CT Patients Face Uncertainty as Giant Insurer and Health System Clash